The affiliation “Independent, Medellin, Columbia” for reviewer Ana Londono was erroneously given as “Independent, Cocos Islands”.
The original version of this article has been updated.
Summary
Keywords
multiple sclerosis, serum biomarkers, serum proteomics, neuroimmunology, demyelinated diseases
Citation
Frontiers Production Office (2026) Correction: New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis. Front. Immunol. 16:1774415. doi: 10.3389/fimmu.2025.1774415
Received
23 December 2025
Accepted
23 December 2025
Published
09 January 2026
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
16 - 2025
Updates
Copyright
© 2026 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.